The Beauty Health Company shares are trading lower after Stifel downgraded the stock from Buy to Hold and lowered its price target from $17 to $10.
Portfolio Pulse from Benzinga Newsdesk
The Beauty Health Company's shares are trading lower after Stifel downgraded the stock from Buy to Hold and lowered its price target from $17 to $10.
June 21, 2023 | 12:33 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The Beauty Health Company's stock downgraded by Stifel from Buy to Hold, with a reduced price target from $17 to $10.
The Beauty Health Company's stock is directly impacted by Stifel's downgrade from Buy to Hold and the lowered price target from $17 to $10. This negative sentiment from a prominent analyst is likely to cause short-term downward pressure on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100